Compass's psilocybin drug has shown positive results in two trials for treating severe depression. The development has been seen as a significant step forward for the use of psychedelic drugs in treating mental health conditions. However, it is unclear how this breakthrough relates to other psychedelic treatments, such as LSD, that are also being researched for similar purposes.